AAPS PharmSciTech · 2006 · 82 citations · 29 references
PharmacyOncologyPharmaceuticsCancer PharmacologyDrug DeliveryTargeted Drug DeliveryCancer Drug DeliveryCancer NanomedicineLiposomal FormulationsLiposome-based DeliveryNanocarriers For TherapeuticsNanoparticle Delivery SystemsIn-vitro CharacterizationLiposomal Delivery SystemsLiposomal NanocarriersLiposome Delivery SystemsLiposome Drug DeliveryLiposomesTargeted LiposomesTumor Vasculature Targeting
29
Michael J. Hope, Marcel B. Bally, G. A. Webb et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1985 · 2.1K citations
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Marc Dellian, Dai Fukumura, Michael Leunig et al. · PubMed · 1995 · 1.7K citations
Medicine, Cancer Biology, Oncology +17
Liposomes: A practical approach
Harish M. Patel · FEBS Letters · 1990 · 1K citations · Full text
Pharmacy, Biophysics, Drug Delivery +11
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
G. Dark, S A Hill, Vivien E. Prise et al. · PubMed · 1997 · 624 citations
Medicine, Oncology, Pharmacology +13